A Cochrane review suggests a decades-old gout drug might protect arteries in a way we usually reserve for “heart medicines.” It points to a surprising link between low-grade immune system inflammation and repeat heart attacks and strokes. For years, cardiovascular prevention has centered on cholesterol, blood pressure, and clot control—while chronic, low-level inflammation has been treated as a background signal rather than a main target. A new Cochrane review uncovers evidence that low-dose col